Note: Ingredients listed on restricted chemical lists
EC/CAS
10081-67-1
Name of the chemical
4-(1-methyl-1-phenylethyl)-N-[4-(1-methyl-1-phenylethyl)phenyl]aniline
Concentration
N/A
General Information
Revision date
2018-09-04
Product name
NAUGALUBE AMS
CAS No.
10081-67-1
1.2.1 Relevant identified uses
This substance is restricted to the following uses
Icons in SDS
Company Information
company name
LANXESS Solutions US Inc
e-mail address of the competent person responsible for the Safety Data Sheet
MSDSRequest@lanxess.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H413
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
OSHA Form powder Colour white to off-white Odour characteristic
2.1 Classification of the substance or mixture
Combustible dust Skin sensitisation : Category 1 Long-term (chronic) aquatic : Category 4
Signal word
Warning
Hazard statements
May form combustible dust concentrations in air. H317 May cause an allergic skin reaction. H413 May cause long lasting harmful effects to aquatic life.
2.3 Other hazards
May form combustible dust concentrations in air during processing, handling or other means.
Prevention
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P272 Contaminated work clothing should not be allowed out of the workplace. P273 Avoid release to the environment. P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P363 Wash contaminated clothing before reuse.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant. Carcinogenicity: IARC No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. OSHA No component of this product present at levels greater than or equal to 0.1% is on OSHA’s list of regulated carcinogens. NTP No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP.
